Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation. (Q46732371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

18

Hironobu Sasano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

Yasuhiro Miki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

12

Takashi Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

9

Kiyoshi Takagi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

16

Takanori Ishida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

17

Noriaki Ohuchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

Tomomi Yoda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

15

Kentaro Tamaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

14

Minoru Miyashita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

13

Noriko Nemoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

4

Niramol Chanplakorn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

7

Youwanush Kongdan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Sansanee Wongwaisayawan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Pimpin Incharoen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lin Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Takagi Mayu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yasuhiro Nakamura

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

15 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

639-646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

Identification of molecular apocrine breast tumours by microarray analysis.

23 February 2020

cites work

1 reference

12 December 2020

Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray

1 reference

12 December 2020

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

1 reference

12 December 2020

Androgen receptor in triple negative breast cancer.

1 reference

12 December 2020

Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer

1 reference

12 December 2020

Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer

1 reference

12 December 2020

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells

1 reference

12 December 2020

Directed therapy of subtypes of triple-negative breast cancer.

1 reference

12 December 2020

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

1 reference

12 December 2020

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

1 reference

12 December 2020

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.

1 reference

12 December 2020

Heterogeneity of breast cancer and implications of adjuvant chemotherapy

1 reference

12 December 2020

Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer

1 reference

12 December 2020

Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells.

1 reference

12 December 2020

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

12 December 2020

Improved measurement of androgen receptors in human breast cancer

1 reference

12 December 2020

5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production

1 reference

12 December 2020

Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates

1 reference

12 December 2020

Androgen sensitivity of the new human breast cancer cell line MFM-223.

1 reference

12 December 2020

Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast

1 reference

12 December 2020

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

1 reference

12 December 2020

Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas

1 reference

12 December 2020

A microarray approach to translational medicine in breast cancer: how representative are cell line models of clinical conditions?

1 reference

12 December 2020

Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells

1 reference

12 December 2020

Life stage differences in mammary gland gene expression profile in non-human primates

1 reference

12 December 2020

Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.

1 reference

12 December 2020

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

1 reference

12 December 2020

Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies

1 reference

12 December 2020

The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality.

1 reference

12 December 2020

Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.

1 reference

12 December 2020

A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines

1 reference

12 December 2020

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

1 reference

12 December 2020

Expression and clinical significance of androgen receptor in triple negative breast cancer.

1 reference

12 December 2020

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

1 reference

12 December 2020

Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer

1 reference

12 December 2020

Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors

1 reference

12 December 2020

Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.

1 reference

12 December 2020

Molecular stratification of triple-negative breast cancers.

1 reference

12 December 2020

Targeting androgen receptor in estrogen receptor-negative breast cancer

1 reference

12 December 2020

Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma

1 reference

12 December 2020

Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells

1 reference

12 December 2020

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

1 reference

12 December 2020

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer

1 reference

12 December 2020

Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients

1 reference

12 December 2020

Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population

1 reference

12 December 2020

Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers

1 reference

12 December 2020

Androgens induce divergent proliferative responses in human breast cancer cell lines.

1 reference

12 December 2020

Intracrinology of estrogens and androgens in breast carcinoma

1 reference

12 December 2020

Triple-negative breast cancer: role of the androgen receptor

1 reference

12 December 2020

EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer.

1 reference

12 December 2020

Choosing the right cell line for breast cancer research

1 reference

12 December 2020

Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

1 reference

12 December 2020

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

12 December 2020

The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.

1 reference

12 December 2020

Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.

1 reference

12 December 2020

An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity

1 reference

12 December 2020

Androgen-dependent regulation of human MUC1 mucin expression

1 reference

12 December 2020

Immunohistochemical categorisation of ductal carcinoma in situ of the breast

1 reference

12 December 2020

Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma.

1 reference

12 December 2020

Molecular heterogeneity of triple-negative breast cancer and its clinical implications

1 reference

12 December 2020

Androgen Receptor Expression in Estrogen Receptor-Negative Breast Cancer Immunohistochemical, Clinical, and Prognostic Associations

1 reference

12 December 2020

Androgen receptor expression and breast cancer survival in postmenopausal women

1 reference

12 December 2020

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer

1 reference

12 December 2020

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer

1 reference

12 December 2020

Prognostic markers in triple-negative breast cancer

1 reference

12 December 2020

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival

1 reference

12 December 2020

Expression of androgen receptor in breast carcinoma and its relationship with estrogen receptor, progesterone receptor and HER2 status

1 reference

12 December 2020

Expression of androgen receptors in primary breast cancer

1 reference

12 December 2020

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.

1 reference

12 December 2020

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.

1 reference

12 December 2020

Check your cultures! A list of cross-contaminated or misidentified cell lines

1 reference

12 December 2020

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

1 reference

12 December 2020

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

1 reference

12 December 2020

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

1 reference

12 December 2020

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PMC publication ID

7657136

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23373898%20AND%20SRC:MED&resulttype=core&format=json